Annolyse
BriefingsCompaniesInsightsPrinciplesCompareChatWatchlist

Explore

  • Briefings
  • Companies
  • Insights
  • Compare

Resources

  • Search
  • Methodology

© 2026 Annolyse.

Company archive

ArborGen Holdings (ARB) briefings

Read that company's published results in release order, newest first.

All briefingsConsumerHealthcareTransport & InfrastructurePrimary IndustriesPropertyInvestment CompaniesTechnologyConstruction & Materials
Open archive
Clear filters

Showing 1-9 of 9 published briefings.

ArborGen Holdings (ARB)•FY26•Released 29 May 2026

Net debt/EBITDA hits 2.2x as EBITDA margin falls below historical range

Revenue grew 7.9% to a five-year high, but margin compression and rising leverage leave cash generation well below ArborGen's historical baseline.

Published 29 May 2026

Read briefing→
ArborGen Holdings (ARB)•HY26•Released 26 November 2025

Pre-lease FCF fell to NZ$-7.2m as gross borrowings rose 61.9% to NZ$34.0m

A NZ$5.0m working-capital build ahead of the seasonally heavy 2H drove OCF from +NZ$2.1m to -NZ$5.4m and required NZ$13.0m of new borrowings.

Published 23 April 2026

Read briefing→
ArborGen Holdings (ARB)•FY25•Released 30 May 2025

Adjusted EBITDA of $11.2m masked a $21.5m statutory loss

Operating cash flow fell 76.9% to $2.7m and free cash flow swung NZ$10.2m to -$5.1m, below the historical NZ$0.9m–$5.1m range.

Published 23 April 2026

Read briefing→
ArborGen Holdings (ARB)•FY24•Released 30 May 2024

Revenue rose 20.7% but PBT swung to a $1.6m loss despite margin gains

NPAT looks 92.0% better on a tax swing while receivable days jumped 47 days and cash halved to $5.6m.

Published 23 April 2026

Read briefing→
ArborGen Holdings (ARB)•HY24•Released 13 December 2023

Revenue jumped 78% on Brazil, but FY24 US seedling guidance cut

A strong first half driven by record Brazil volumes is shadowed by a downward revision to US seedling sales in the heavier second half.

Published 23 April 2026

Read briefing→
ArborGen Holdings (ARB)•FY23•Released 30 May 2023

ArborGen FY23: $11.3m working-capital release drove the cash uplift

PBT swung to US$0.9m and EBITDA rose 35%, but an unusually favourable working-capital release supplied most of the cash flow lift.

Published 23 April 2026

Read briefing→
ArborGen Holdings (ARB)•HY23•Released 29 November 2022

Continuing-ops revenue up 60.9% but FCF burn widened to NZ$4.8m

Strong gross-margin expansion was overshadowed by negative operating cash flow in a seasonally light half, with NPAT optics distorted by the

Published 23 April 2026

Read briefing→
ArborGen Holdings (ARB)•FY22•Released 30 May 2022

Working capital absorbed US$25.6m as PBT swung to a US$3.0m loss

Continuing-ops revenue grew 11.2%, but a 156.7% effective tax rate flipped a PBT loss to US$1.7m NPAT while inventories built US$27.3m.

Published 23 April 2026

Read briefing→
ArborGen Holdings (ARB)•HY22•Released 24 November 2021

Revenue fell 61% as a discontinued ANZ operation reshaped the result

Continuing-operations revenue lifted but a NZ$0.6m discontinued-operation gain is the only reason headline NPAT stayed positive at NZ$0.1m.

Published 23 April 2026

Read briefing→

Get reporting-season briefings

Get full NZX result briefings by email as new coverage is published.